#immunoconjugate — Friday, October 30, 2026 (1 items)
| 14 | ℹ |
Engineered receptor-biased IL-2-drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-10-30 | #immunotherapy #autoimmune #inflammation #cytokine #immunoconjugate |